Aktienbewertung
Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Teva Pharmaceutical Industries NYSE:TEVA |
18,97 Mrd. $ | -0,24 % | 4/6 | 2,27 % | -69,92 % | 39,06 % | UP |
|
Hikma Pharmaceuticals PLC LSE:HIK |
4,36 Mrd. £ | 3,94 % | 4/6 | -2,01 % | 1,38 % | 33,05 % | DOWN |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,10 Mrd. $ | 7,03 % | 3/6 | -16,33 % | -3,27 % | 19,58 % | UP |
|
ANI Pharmaceuticals NasdaqGM:ANIP |
1,29 Mrd. $ | 5,65 % | 4/6 | 27,14 % | 19,13 % | 31,62 % | UP |
|
Amphastar Pharmaceuticals NasdaqGS:AMPH |
1,02 Mrd. $ | 34,20 % | 5/6 | -12,24 % | 59,42 % | 38,44 % | DOWN |
|
Pacira BioSciences NasdaqGS:PCRX |
1,00 Mrd. $ | 11,18 % | 5/6 | -2,60 % | 61,12 % | 38,82 % | DOWN |
|
Collegium Pharmaceutical NasdaqGS:COLL |
1,00 Mrd. $ | 31,58 % | 6/6 | 19,76 % | 21,20 % | 40,98 % | UP |
|
Zevra Therapeutics NasdaqGS:ZVRA |
0,59 Mrd. $ | -35,96 % | 1/5 | 294,27 % | -38,52 % | 117,39 % | UP |
|
Aquestive Therapeutics NasdaqGM:AQST |
0,39 Mrd. $ | -17,96 % | 4/6 | -20,99 % | -338,23 % | 103,56 % | UP |
|
Delcath Systems NasdaqCM:DCTH |
0,37 Mrd. $ | 0,00 % | 1/2 | 154,92 % | 38,90 % | 115,40 % | DOWN |
|
Emergent BioSolutions NYSE:EBS |
0,35 Mrd. $ | -10,61 % | 0/6 | 2,42 % | 44,23 % | 107,69 % | UP |
|
Ironwood Pharmaceuticals NasdaqGS:IRWD |
0,14 Mrd. $ | -13,09 % | 3/6 | 0,99 % | 81,91 % | 12,36 % | DOWN |
|
Assertio Holdings NasdaqCM:ASRT |
0,07 Mrd. $ | -41,51 % | 0/6 | -42,09 % | -55,43 % | 322,54 % | DOWN |
|
Cumberland Pharmaceuticals NasdaqGS:CPIX |
0,05 Mrd. $ | 0,00 % | 0/0 | 0,00 % | 0,00 % | -100,00 % | UP |
|
DURECT NasdaqCM:DRRX |
0,06 Mrd. $ | -31,36 % | 2/6 | -82,61 % | -218,40 % | 32,98 % | DOWN |
|
Talphera NasdaqGM:TLPH |
0,01 Mrd. $ | 0,00 % | 4/5 | 0,00 % | 0,00 % | 638,64 % | DOWN |
